TipRanks
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded Fund
Advertisement

IN:PHARMABEES ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Neutral
8Bullish
4Neutral
10Bearish
Oscillators
Buy
4Bullish
4Neutral
2Bearish
Moving Averages
Sell
4Bullish
0Neutral
8Bearish
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Nippon India Nifty Pharma ETF Units Exchange Traded Fund is a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 20-Day exponential moving average is 27.26, making it a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-Day exponential moving average is 27.12, making it a Sell.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Pivot Points

Oct 13, 2026, 05:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
25.31
25.90
26.27
26.86
27.23
27.82
28.19
Fibonacci
25.90
26.27
26.50
26.86
27.23
27.46
27.82

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Moving Averages

Oct 13, 2026, 05:27 AM
Period
Simple
Exponential
MA5
26.94Sell
26.95Sell
MA10
27.24Sell
27.13Sell
MA20
27.34Sell
27.26Sell
MA50
27.34Sell
27.12Sell
MA100
26.53Buy
26.48Buy
MA200
24.90Buy
25.17Buy
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 10-Day exponential moving average is 27.13, making it a Sell.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-Day exponential moving average is 26.48, making it a Buy.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 50-day simple moving average is 27.34, creating a Sell signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 100-day simple moving average is 26.53, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) 200-day simple moving average is 24.90, creating a Buy signal.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund (PHARMABEES) Technical Analysis

Oct 13, 2026, 05:27 AM
Name
Value
Action
RSI (14)
41.76
Neutral
STOCH (9,6)
23.72
Neutral
STOCHRSI (14)
25.85
Neutral
MACD (12,26)
-0.10
Buy
ADX (14)
16.41
Buy
Williams %R
-68.50
Buy
CCI (14)
-155.21
Buy
ATR (14)
0.95
-
Ultimate Oscillator
40.87
Neutral
ROC
-2.69
Sell
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Relative Strength Index (RSI) is 41.76, creating a Neutral signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Trend Strength Indicator (ADX) is 16.41, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Commodity Channel Index (CCI) is -155.21, creating a Buy signal.
Nippon India Nifty Pharma ETF Units Exchange Traded Fund’s (PHARMABEES) Price Rate of Change (ROC) is -2.69, creating a Sell signal.

FAQ

Is PHARMABEES a Buy, Hold, or Sell?
Based on PHARMABEES’s technical indicators, PHARMABEES is a Hold.
    What is PHARMABEES’s RSI (14)?
    PHARMABEES’s RSI (14) is 41.76, which suggests PHARMABEES is a Neutral.
      What is PHARMABEES’s MACD?
      PHARMABEES’s MACD is -0.10, which suggests PHARMABEES is a Buy.
        What is PHARMABEES’s 5-day moving average?
        PHARMABEES’s 5-day moving average is 26.94, which suggests PHARMABEES is a Sell.
          What is PHARMABEES’s 20-day moving average?
          PHARMABEES 20-day moving average is 27.34, which suggests PHARMABEES is a Sell.
            What is PHARMABEES’s 50-day moving average?
            PHARMABEES’s 50-day moving average is 27.34, which suggests PHARMABEES is a Sell.
              What is PHARMABEES’s 200-day moving average?
              PHARMABEES’s 200-day moving average is 24.90, which suggests PHARMABEES is a Buy.
                What is PHARMABEES’s Williams % R (14)?
                PHARMABEES’s Williams % R (14) is -68.50, which suggests PHARMABEES is a Buy.
                  What is PHARMABEES’s CCI (14)?
                  PHARMABEES’s CCI (14) is -155.21, which suggests PHARMABEES is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement